| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |